News

Once again the AREVIR meeting brought together an international community of researchers to share insights, challenge perspectives, and advance the understanding of viral infections . Across the day, the programme highlighted key topics shaping current research, from viral dynamics and immune responses to emerging challenges in infectious diseases and public health. The EuCARE /VIROMARKERS session […]

The AREVIR Meeting 2026 is almost here, and this year features a special joint session with the EuCARE and VIROMARKERS projects! Join us for presentations by leading scientists, sharing preliminary activities, current findings, and future steps to tackle evolving challenges in infectious diseases. 🗓 Date: April 24, 2026📍 Location: Cologne, Germany Check out the agenda

We’re launching a new series of short testimonials from the people behind the project. Researchers, clinicians, and partners across Europe and beyond, sharing what EuCARE represents to them. We start with the team from Pomeranian Medical University, reflecting on collaboration, science, and the shared mission that connects us. For the Portuguese team, EuCARE means collaboration,

From June 10-12, this leading European meeting will bring together experts in HIV, hepatitis, and antiviral resistance to share insights, research, and clinical advances. 🔬 From treatment strategies to emerging challenges, the programme covers key topics shaping the future of infectious diseases. ⏳ Registration is open: don’t miss the opportunity to be part of the

On April 24–25, we’ll once again join this highly specialised international meeting in Cologne: a key moment to share insights, results, and ongoing work. Our joint EuCARE / VIROMARKERS session will take place on April 24, from 9:10 AM to 12:00 PM. A space for science, exchange, and new perspectives. The programme is almost available

A new study by Francis Drobniewski and Marcia Ashmi shows that even healthcare workers (the ones we trust most) can be hesitant about vaccination. Despite their key role in building public trust, vaccination uptake among healthcare professionals remains suboptimal. For example, recent data show influenza vaccination rates of around 40–50% among frontline HCWs in England.

We are pleased to share that two abstracts from the IEO team, within the EuCARE project, have been selected for oral presentations at the EBMLive 2026 Conference. 🔹 Giulia DoiMeta-analysis on the prevalence of anxiety, depression and distress among cancer patients during the COVID-19 pandemic, by type of treatment and cancer.This abstract has been selected

We are pleased to share that two abstracts from the EuCARE project have been presented at the Conference on Retroviruses and Opportunistic Infections (CROI). One of the abstracts, “Gut–Lung Axis Disruption in Long COVID Uncovered by Integrated Immuno-Epithelial-Microbial Profiling”, was presented by Roberta Rovito the Clinic of Infectious Diseases and Tropical Medicine at San Paolo

EuCARE will continue as a non-financial endorser of the 24th European Meeting on HIV & Hepatitis (EMMH) 2026. 📍 Barcelona, Spain📅 10–12 June 2026 We encourage researchers, clinicians and healthcare professionals within our network to submit their abstracts and contribute to the scientific exchange. 👉 Abstract deadline: 6 March 2026 This meeting represents an important

EuCARE received an “outstanding” rating of scientific excellence in the project’s recent external review. The reviewers praised the high number of publications, the relevant data, and the evidence-based knowledge obtained on the SARS-CoV-2 epidemic. In addition to the scientific quality, they also highlighted the excellent problem-solving skills, flexibility in an ever-changing context, endurance and engagement